Science: Holy Grail of the tropics

Malaria has confounded scientists for decades, but now there may be a vaccine that works.

At the end of a maze of corridors in an anonymous building at Leeds University is a locked door. "It's a little warm in here," says Professor Mike Hollingdale as he leads the way inside. In fact the atmosphere hits you in the face like a hot flannel, causing beads of perspiration spontaneously to erupt across your forehead.

The small, white-walled room is bare save for a sink and a couple of laboratory benches. On one bench is an array of what look like washing- up bowls, each containing a few inches of water. Inside these, swarms of brown larvae dart frantically, or cluster around pellets of dog meal. On the other bench are a pair of cages draped in white mesh. From these comes a familiar, slightly irritating high-pitched whine.

The stuffy, humid room is a mosquito hatchery. It is part of a facility - unique in this country - capable of growing cultures of Plasmodium falciparum - the most important of the four species of the Plasmodium parasite responsible for one of the world's most insidious and devastating diseases, one that kills about three million people each year, mostly children. Professor Hollingdale is on the trail of the Holy Grail of tropical medicine - the development of a malaria vaccine.

The problem of malaria is worsening, and many experts believe that the only realistic solution is the development of a vaccine. But more than two decades of apparent breakthroughs followed by disappointing setbacks have shown that the challenge is far from straightforward.

Part of the difficulty undoubtedly lies in the complex life-cycle of the parasite. P. falciparum is a single-celled organism transmitted by the female mosquito. The form of the organism when it is inside the mosquito is called the sporozoite. When an infected mosquito bites someone, it injects around 100 sporozoites into their blood.

These travel in the bloodstream until they reach the liver. Here, a special protein on the surface of the sporozoite, termed CSP, recognises that it has arrived at the liver and anchors itself to the outside of the cell. The sporozoite then crosses into the liver. Once inside the liver cell, the organism changes shape, from being long and thin to being bloated and spherical. This is termed the schizont stage, and within the schizont thousands of nuclei begin to develop. Eventually maybe 20,000 daughter parasites will form.

These are called merezoites and their sheer volume causes the liver cell to burst open, releasing them into the bloodstream. When a merezoite meets a circulating red blood cell it attaches itself to the surface and enters. Once inside it divides into 15 or 20 daughters in 48 hours. These rupture the blood cell and are released to infect new cells. It is at this stage that the symptoms of malaria appear.

Vaccines work by giving the body's immune system a "preview" of a harmful pathogen - or the relevant bit of it. This allows us to manufacture the appropriate defence hardware rapidly in the event of an invasion by the real thing.

In the early 1970s it was shown that irradiated sporozoites, created by irradiating infected mosquitoes, could confer protection. This, however, is not a feasible way of delivering mass vaccination.

"The experiments with the irradiated sporozoites told us that it is possible to develop a vaccine," says Professor Brian Greenwood, of the London School of Hygiene and Tropical Medicine, who has been involved with vaccine trials in Africa. "The problem is how to devise a simple and practical way of doing it."

In the late Eighties, a putative vaccine was developed by a Colombian scientist, Manual Patarroyo. This consisted of fragments of proteins found on the surface of the parasite artificially stitched together. Early trials suggested that the vaccine produced a high degree of protection, but later studies have cast serious doubt on its effectiveness.

A series of vaccines have been developed based on the CSP. These have given varying degrees of, usually limited, protection. A field trial in The Gambia has just been completed on the latest version of a CSP vaccine, and the results are being analysed. Altogether, says Professor Greenwood, there are about 20 candidate vaccines in development.

The Leeds laboratory is one of the few places in the world able to produce the parasite under conditions which effectively mimic what goes on in sub-Saharan Africa. The parasite is first grown in blood cultures. The infected cultures are then covered by a latex membrane to simulate human skin (condoms were used in early tests). Mosquitoes are allowed to settle on the membrane and take up the parasite. These are then removed from the mosquito's body and transferred to the cultured liver cells.

Under these controlled conditions, scientists can arrest the parasite's life-cycle at any point to scrutinise the biochemical interactions taking place - which genes are active at a given time, or which proteins are essential to a particular series of events. Professor Hollingdale's team is especially interested in a protein called LSA-1. This is a large protein secreted by the parasite as it sits in the liver cells. The protein is an antigen - it elicits an immune response - in other words it stimulates the immune defences to attack it, which makes it a good candidate for a vaccine.

LSA-1 appears to activate one particular aspect of the immune defence, T-cells. These are specialised cells that are produced by the body to seek out and destroy any of the body's cells which are infected by foreign invaders. Professor Hollingdale's team has been working with adult volunteers in Papua New Guinea. By taking samples of blood and adding LSA-1 or specific fragments of the protein, they wanted to see if T-cells were produced by the blood. "Some of the volunteers had previously built up a natural protection to malaria while others had not. The group who were protected had T-cells to LSA-1 in their blood, while the group who were not protected didn't have any. This had never previously been shown and to us strongly implicated that T-cells were important in conferring protection.

"We believe that from these studies and others that there is a strong rationale for producing a vaccine based on LSA-1," says Professor Hollingdale.

The team is looking at a variety of methods to deliver the antigen as a vaccine, and is looking for funding to begin human trials within two years. The European Union has recently earmarked a budget for malaria research and Professor Hollingdale is hoping to help set up a European network to develop a concerted research effort into the development of a vaccine.

"Europe has generated a lot of the candidates for vaccines but has not really had the capital or unity to take these into the complex areas of clinical testing," says Dr David Arnot of Edinburgh University, who has been studying the molecular biology of the malaria parasite for 20 years. "Now we have the opportunity to work in close harness, which I think is an excellent thing. I am reasonably optimistic that within 10 years of good support, and with all the groups pulling hard in a concerted effort, we have a good chance of getting something to work."

Professor Greenwood agrees on the value of a united European approach. "We have been strong on the laboratory side but not had a great presence in testing potential vaccines. Hopefully this EU initiative will go some way to bridging that gap."

As for the prospects for a vaccine, Professor Greenwood remains cautious but optimistic. "For the past 20 years people have been saying `we'll have a vaccine within five years' - and they are still saying it. My own feeling is that we are unlikely to see a dramatic breakthrough, but rather an accumulation of gradual improvements. I think it is right that we follow the diverse approaches that we are pursuing now, and hope that out of this someone will hit upon something that works."

Arts and Entertainment
Victoria Wood, Kayvan Novak, Alexa Chung, Chris Moyles
tvReview: No soggy bottoms, but plenty of other baking disasters on The Great Comic Relief Bake Off
Arts and Entertainment
80s trailblazer: comedian Tracey Ullman
tv
Arts and Entertainment
Stephen Tompkinson is back as DCI Banks
tvReview: Episode one of the new series played it safe, but at least this drama has a winning formula
Arts and Entertainment
TV
News
Graham Norton said Irish broadcaster RTE’s decision to settle was ‘moronic’
TV
Arts and Entertainment
Attenborough with the primates
tv
Arts and Entertainment
Former Communards frontman Jimmy Somerville
music
Have you tried new the Independent Digital Edition apps?
Arts and Entertainment

ebooksNow available in paperback
Arts and Entertainment

ebooks
Arts and Entertainment
Secrets of JK Rowling's Harry Potter workings have been revealed in a new bibliography
arts + ents
Arts and Entertainment
Fearne Cotton is leaving Radio 1 after a decade
radio The popular DJ is leaving for 'family and new adventures'
Arts and Entertainment
arts + ents
Arts and Entertainment
Public Service Broadcasting are going it alone
music
Arts and Entertainment
Eddie Redmayne as transgender artist Lili Elbe in The Danish Girl
filmFirst look at Oscar winner as transgender artist
Arts and Entertainment
Season three of 'House of Cards' will be returning later this month
TV reviewHouse of Cards returns to Netflix
Arts and Entertainment
Harrison Ford will play Rick Deckard once again for the Blade Runner sequel
film review
Arts and Entertainment
The modern Thunderbirds: L-R, Scott, Virgil, Alan, Gordon and John in front of their home, the exotic Tracy Island
TV
Arts and Entertainment
Natural beauty: Aidan Turner stars in the new series of Poldark
TV
Arts and Entertainment
Taylor Swift won Best International Solo Female (Getty)

Brits 2015
Arts and Entertainment
Shining star: Maika Monroe, with Jake Weary, in ‘It Follows’
film review
Arts and Entertainment

Brits 2015
Arts and Entertainment
Paloma Faith arrives at the Brit Awards (Getty)

Brits 2015
Arts and Entertainment
Anne Boleyn's beheading in BBC Two's Wolf Hall

TV review
Arts and Entertainment
Follow every rainbow: Julie Andrews in 'The Sound of Music'
film Elizabeth Von Trapp reveals why the musical is so timeless
Arts and Entertainment
Bytes, camera, action: Leehom Wang in ‘Blackhat’
film
Arts and Entertainment
The Libertines will headline this year's festival
music
Arts and Entertainment
Richard Dean Anderson in the original TV series, which ran for seven seasons from 1985-1992
tv
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    War with Isis: Iraq's government fights to win back Tikrit from militants - but then what?

    Baghdad fights to win back Tikrit from Isis – but then what?

    Patrick Cockburn reports from Kirkuk on a conflict which sectarianism has made intractable
    Living with Alzheimer's: What is it really like to be diagnosed with early-onset dementia?

    What is it like to live with Alzheimer's?

    Depicting early-onset Alzheimer's, the film 'Still Alice' had a profound effect on Joy Watson, who lives with the illness. She tells Kate Hilpern how she's coped with the diagnosis
    The Internet of Things: Meet the British salesman who gave real-world items a virtual life

    Setting in motion the Internet of Things

    British salesman Kevin Ashton gave real-world items a virtual life
    Election 2015: Latest polling reveals Tories and Labour on course to win the same number of seats - with the SNP holding the balance of power

    Election 2015: A dead heat between Mr Bean and Dick Dastardly!

    Lord Ashcroft reveals latest polling – and which character voters associate with each leader
    Audiences queue up for 'true stories told live' as cult competition The Moth goes global

    Cult competition The Moth goes global

    The non-profit 'slam storytelling' competition was founded in 1997 by the novelist George Dawes Green and has seen Malcolm Gladwell, Salman Rushdie and Molly Ringwald all take their turn at the mic
    Pakistani women come out fighting: A hard-hitting play focuses on female Muslim boxers

    Pakistani women come out fighting

    Hard-hitting new play 'No Guts, No Heart, No Glory' focuses on female Muslim boxers
    Leonora Carrington transcended her stolid background to become an avant garde star

    Surreal deal: Leonora Carrington

    The artist transcended her stolid background to become an avant garde star
    LGBT History Month: Pupils discuss topics from Sappho to same-sex marriage

    Education: LGBT History Month

    Pupils have been discussing topics from Sappho to same-sex marriage
    11 best gel eyeliners

    Go bold this season: 11 best gel eyeliners

    Use an ink pot eyeliner to go bold on the eyes with this season's feline flicked winged liner
    Cricket World Cup 2015: Tournament runs riot to make the event more hit than miss...

    Cricket World Cup runs riot to make the event more hit than miss...

    The tournament has reached its halfway mark and scores of 300 and amazing catches abound. One thing never changes, though – everyone loves beating England
    Katarina Johnson-Thompson: Heptathlete ready to jump at first major title

    Katarina Johnson-Thompson: Ready to jump at first major title

    After her 2014 was ruined by injury, 21-year-old Briton is leading pentathlete going into this week’s European Indoors. Now she intends to turn form into gold
    Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

    Climate change key in Syrian conflict

    And it will trigger more war in future
    How I outwitted the Gestapo

    How I outwitted the Gestapo

    My life as a Jew in wartime Berlin
    The nation's favourite animal revealed

    The nation's favourite animal revealed

    Women like cuddly creatures whilst men like creepy-crawlies
    Is this the way to get young people to vote?

    Getting young people to vote

    From #VOTESELFISH to Bite the Ballot